Lloyd Price

APRIL 27, 2024

Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Visit www.nelsonadvisors.co.uk

healthcare technology 73

healthcare technology Leadership Drug Development Digital Health 73

Lloyd Price

SEPTEMBER 16, 2024

The conference explored the advancements in precision medicine and its implications for healthcare delivery. Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry.

Digital Health 64

Digital Health Drug Development healthcare technology Leadership 64

Lloyd Price

NOVEMBER 8, 2024

The increasing adoption of digital health technologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Digital Health 52

Digital Health healthcare technology Pharmaceuticals Telehealth 52

Lloyd Price

MAY 2, 2024

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology 73

healthcare technology Drug Development Leadership Digital Health 73

Lloyd Price

APRIL 29, 2024

Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data 64

Health Data healthcare technology Digital Health Leadership 64

Lloyd Price

FEBRUARY 18, 2024

AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Remote care 64

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Interoperability 73

Interoperability healthcare technology HIPAA Leadership 73

Lloyd Price

MAY 6, 2024

By incorporating the strengths of weather AI, healthcare AI can become even more powerful in predicting, preventing, and managing health issues, leading to a more personalised and proactive healthcare system. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

healthcare technology 70

healthcare technology Leadership Drug Development Digital Health 70

Lloyd Price

APRIL 22, 2024

Growing Market: The global market for AI in healthcare is projected to reach astronomical figures in the coming years, reflecting the confidence in this technology. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology 60

healthcare technology Leadership Drug Development Digital Health 60

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

OCTOBER 9, 2024

Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Mental health 60

Mental health healthcare technology Leadership Digital Health 60

Lloyd Price

AUGUST 7, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Interoperability 60

Interoperability Leadership EHR Drug Development 60

Lloyd Price

DECEMBER 2, 2024

By embracing technological advancements, focusing on personalised medicine, and addressing the challenges of chronic wounds, the industry can improve patient outcomes, reduce costs, and enhance the overall quality of care. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Digital Health 56

Digital Health healthcare technology Telemedicine Leadership 56

Lloyd Price

FEBRUARY 2, 2024

Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times.

Health Data 64

Health Data Interoperability healthcare technology Leadership 64

Lloyd Price

JULY 15, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Digital Health 60

Digital Health Mobile Health Telehealth Leadership 60

Lloyd Price

SEPTEMBER 6, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership 75

Leadership Drug Development healthcare technology Digital Health 75

Lloyd Price

FEBRUARY 22, 2024

Overall, the pain management market is poised for significant growth, fuelled by technological innovation and a growing demand for effective, non-opioid solutions. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Pain management 56

Pain management Mental health Telehealth healthcare technology 56

Lloyd Price

SEPTEMBER 29, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership 64

Leadership Drug Development healthcare technology Digital Health 64

Healthcare IT Today

MAY 5, 2023

Whereas a traditional visit to the doctor can analyze one’s physical health in a fixed time, technology can gather data throughout a patient’s lived experiences, helping healthcare professionals understand patient backgrounds, experiences, and personal preferences on a deeper level. Tanja Dowe, CEO of Debiopharm Innovation Fund S.A.

Drug Development 111

Drug Development Primary Care Remote care Patient Experience 111